Advanced search
Publication Cover
Journal of Pain Research Volume 17, 2024 - Issue
Submit an article Journal homepage
63
Views
0
CrossRef citations to date
0
Altmetric
Cancer Pain and Palliative Care

Current Status of Cognition and Clinical Practice of Refractory Cancer Pain in Shanghai: A Questionnaire Survey

Jing Zhang1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-6057-1460
ORCID Icon,
Ke Ma3 Department of Pain Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Jun Yan4 Department of Oncology, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, People’s Republic of China
,
Pingsheng Pan5 Department of Oncology, Fangta Hospital of Traditional Chinese Medicine in Songjiang District, Shanghai, People’s Republic of China
,
Jiangshan Yin6 Department of Oncology, Fudan University Shanghai Cancer Center, Minhang Branch, Shanghai, People’s Republic of China
,
Fuqing Lin7 Department of Anaesthesiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China
,
Hui Chen8 Department of Anesthesiology and Perioperative Medicine, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, Shanghai, People’s Republic of China
,
Weiwei Zhao1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Menglei Chen1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Zhe Zhang1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Minghui Liu1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Xiaoli Gu1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Xinghe Liao1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-6158-4693
ORCID Icon,
Chenyue Zhang1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
&
Wenwu Cheng1 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1413-1422 | Received 19 Dec 2023, Accepted 04 Apr 2024, Published online: 09 Apr 2024
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Purpose

This study aimed to assess the current status of clinical practice of refractory cancer pain (RCP) among a sample of physicians specializing in cancer pain management in Shanghai.

Methods

From 2019 to 2021, a questionnaire survey was conducted among physicians engaged in diagnosis and treatment of cancer pain through the questionnaire WJX network platform in Shanghai, China.

Results

A total of 238 responses participated in the survey. This survey reports physicians’ understanding and incidence rate of breakthrough cancer pain (BTCP). The choice of analgesics and satisfaction of analgesic effect were investigated. We also investigated doctors’ knowledge of the diagnostic criteria for RCP and their tendency to choose analgesics. Oral immediate-release morphine and intravenous or subcutaneous morphine injection have been the common treatment approach for transient cancer pain exacerbations. The main barriers to pain management are lack of standardized treatment methods for RCP, lack of knowledge related to RCP, and single drug dosage form. Doctors believe the most necessary measures to improve the current situation of poor cancer pain control include improving medical staff’s understanding and treatment techniques for RCP, updating treatment techniques and methods, and improving the configuration of drug types in medical institutions. Clinicians expect to improve understanding and treatment techniques through systematic training.

Conclusion

Despite multiple available analgesic measures, the treatment of RCP remains challenging. Improving the understanding of medical staff towards RCP, improving treatment techniques, and increasing the accessibility of multiple drug types are important ways to improve the satisfaction of cancer pain management in the future.

This article is part of the following collections:
Cancer Pain

Disclosure

The authors declare no competing interests in this work.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.